Abiomed Inc.'s (ABMD) international expansion gets a boost with the medical product developer gaining the Japanese PMDA approval for its Impella 2.5 and Impella 5.0 heart pumps.
- GlobeNewswire•2 days agoAbiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare
DANVERS, Mass., Sept. 27, 2016-- Abiomed, Inc., a leading provider of breakthrough heart support technologies, announced today that the Impella 2.5 and Impella 5.0 heart pumps received Pharmaceuticals ...
ABIOMED, Inc. (ABMD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||130.01 x 200|
|Ask||130.18 x 200|
|Day's Range||129.01 - 131.16|
|52wk Range||67.81 - 131.16|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||137.40|
|Avg Vol (3m)||457,950|
|Dividend & Yield||N/A (N/A)|